Two-gene test predicts which patients with heart failure respond best to beta-blocker drug
Tuesday, October 16, 2012 - 10:30
in Health & Medicine
A landmark paper identifying genetic signatures that predict which patients respond to a life-saving drug for congestive heart failure has just been published. Medical researchers discovered and characterized the two genetic variations that determine how patients are likely to respond to the beta-blocker bucindolol.